Logo

CombiMatrix Shares Jump 12 Percent on European Patent Award

Mar 16, 2006

NEW YORK, March 16 (GenomeWeb News) - Shares of CombiMatrix were up 12.4 percent, or $.24, at $2.18 in afternoon trading after parent Acacia announced that the European patent office had granted CombiMatrix a patent titled "self-assembling arrays" (EP1185363B1).

 

The patent was registered in Germany, France, Spain, Great Britain, and Italy, the company said in a statement.

 

A corresponding patent is pending in the US.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.